semaglutide sketchy Patients struggle as compounded GLP-1 access rapidly shrinks Novo Nordisk is slashing GLP-1

Publicly available data from the ESSENCE trial do not allow an assessment of blood tests and other NITs that predict response to treatment (and this is generally an unmet need in clinical trials of MASH pharmacotherapy)

Seek immediate medical attention (call 999) if you experience severe chest pain, breathlessness, loss of consciousness, or irregular heartbeat whilst taking weight loss medications

The global GLP-1 receptor agonist market is projected to soar from USD 28.19 billion in 2025 to USD 63.54 billion by 2032, reflecting a compound annual growth rate of 12.3%

Gentle physical activity can also aid digestion

A calorie deficit occurs when a person consumes fewer calories than their body needs, causing the body to use stored fat for energy

Haqq AM, Chung WK, Dollfus H, Haws RM, Martos-Moreno G, Poitou C, et al